Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept
✍ Scribed by D. van der Heijde; R. Landewé; S. Einstein; P. Ory; D. Vosse; L. Ni; S.-L. Lin; W. Tsuji; J. C. Davis Jr.
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 103 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective To examine the long‐term outcome of patients with active ankylosing spondylitis (AS) clinically and by magnetic resonance imaging (MRI) after continuous treatment with the tumor necrosis factor (TNF) receptor fusion protein etanercept over 2 years. ## Methods Overall, 26
A group of 40 individuals were restudied at a median follow-up time of 18 years after chest surgery, chest irradiation, or cyclophosphamide treatment. Their median age at diagnosis was 4.5 years. Nineteen subjects were operated on in the chest area. Radiotherapy of the chest had been used in 21 and